19-05-2025, 23:15

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Notified -
Globe Newswire19-05-2025, 23:15
16-01-2025, 22:05

Boehringer provides update on iclepertin Phase III program in schizophrenia

Notified -
Globe Newswire16-01-2025, 22:05
4-11-2024, 20:57

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
Globe Newswire4-11-2024, 20:57
1-11-2024, 01:22

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
Globe Newswire1-11-2024, 01:22
9-09-2024, 22:45

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Globe Newswire9-09-2024, 22:45
15-07-2024, 21:29

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
Globe Newswire15-07-2024, 21:29